Cargando…
Mechanistic insights into influenza vaccine-associated narcolepsy
We previously reported an increased frequency of antibodies to hypocretin (HCRT) receptor 2 in sera obtained from narcoleptic patients who received the European AS03-adjuvanted vaccine Pandemrix (GlaxoSmithKline Biologicals, s.a.) for the global influenza A H1N1 pandemic in 2009 [A(H1N1)pdm09]. Thes...
Autores principales: | Ahmed, S. Sohail, Steinman, Lawrence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215445/ https://www.ncbi.nlm.nih.gov/pubmed/27031682 http://dx.doi.org/10.1080/21645515.2016.1171439 |
Ejemplares similares
-
Mass Spectrometric Characterization of Narcolepsy-Associated Pandemic 2009 Influenza Vaccines
por: Ambati, Aditya, et al.
Publicado: (2020) -
Pandemrix™ and narcolepsy: A critical appraisal of the observational studies
por: Verstraeten, Thomas, et al.
Publicado: (2015) -
Proteogenomics unveils mechanistic insights to precision oncology
por: Dou, Yongchao, et al.
Publicado: (2023) -
Narcolepsy, autoimmunity, and influenza A H1N1 vaccination
por: Sunwoo, Jun-Sang
Publicado: (2021) -
Adjuvanted AH1N1 influenza vaccine precipitating the appearance of narcolepsy()
por: Boquete Castro, A., et al.
Publicado: (2021)